NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Plantik Biosciences

Plantik Biosciences

Private
ParisHealthcare & Life Scienceshttps://www.plantik.bio/

Last Round

Accelerator

Nov 13, 2024

Total Funding Raised

$2.1M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Plantik Biosciences is an agritech company that develops climate-resilient crops using next-generation plant engineering and genome-editing technologies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, ML Platforms

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Government Contracts

AI Layer

Application

Keywords

genome editingagricultural biotechnologyCRISPRagtechclimate-resilient cropplant engineeringgene editingtrait developmentgenome analysis platformheat-tolerant cropplant breeding technologydark genome analysistrait licensingthermotolerant trait

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Plantik Biosciences Comparables

Compare Plantik Biosciences with similar companies based on industry and business-model similarity.

Plantik Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Plantik Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorNov 13, 2024
SeedFeb 6, 2024
GrantSep 13, 2022
AcceleratorJan 5, 2022
AcceleratorSep 10, 2020
Accelerator
Apr 8, 2020

Key People

Founding team and executive leadership

Ying Shao

Co-Founder & CEO

Founding Team

Plantik Biosciences Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 15, 2026

    Monthly visitors grew 96% MoM.

  • Feb 19, 2026

    Grew 50% QoQ from 6 to 9 employees.

Plantik Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Plantik Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Plantik Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersParis
Employee Range10
Year Founded2019
Last FundingNov 13, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.